Literature DB >> 35263652

Short-term PM2.5 exposure and early-readmission risk: a retrospective cohort study in North Carolina heart failure patients.

Lauren H Wyatt1, Anne M Weaver1, Joshua Moyer1, Joel D Schwartz2, Qian Di3, David Diaz-Sanchez1, Wayne E Cascio1, Cavin K Ward-Caviness4.   

Abstract

BACKGROUND: Short-term changes in ambient fine particulate matter (PM2.5) increase the risk for unplanned hospital readmissions. However, this association has not been fully evaluated for high-risk patients or examined to determine if the readmission risk differs based on time since discharge. Here we investigate the relation between ambient PM2.5 and 30-day readmission risk in heart failure (HF) patients using daily time windows and examine how this risk varies with respect to time following discharge.
METHODS: We performed a retrospective cohort study of 17,674 patients with a recorded HF diagnosis between 2004 and 2016. The cohort was identified using the EPA CARES electronic health record resource. The association between ambient daily PM2.5 (μg/m3) concentration and 30-day readmissions was evaluated using time-dependent Cox proportional hazard models. PM2.5 associated readmission risk was examined throughout the 30-day readmission period and for early readmissions (1-3 days post-discharge). Models for 30-day readmissions included a parametric continuous function to estimate the daily PM2.5 associated readmission hazard. Fine-resolution ambient PM2.5 data were assigned to patient residential address and hazard ratios are expressed per 10 μg/m3 of PM2.5. Secondary analyses examined potential effect modification based on the time after a HF diagnosis, urbanicity, medication prescription, comorbidities, and type of HF.
RESULTS: The hazard of a PM2.5-related readmission within 3 days of discharge was 1.33 (95% CI 1.18-1.51). This PM2.5 readmission hazard was slightly elevated in patients residing in non-urban areas (1.43, 95%CI 1.22-1.67) and for HF patients without a beta-blocker prescription prior to the readmission (1.35; 95% CI 1.19-1.53).
CONCLUSION: Our findings add to the evidence indicating substantial air quality-related health risks in individuals with underlying cardiovascular disease. Hospital readmissions are key metrics for patients and providers alike. As a potentially modifiable risk factor, air pollution-related interventions may be enacted that might assist in reducing costly and burdensome unplanned readmissions. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35263652      PMCID: PMC9064928          DOI: 10.1016/j.ahj.2022.02.015

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   5.099


  33 in total

1.  A framework for public health action: the health impact pyramid.

Authors:  Thomas R Frieden
Journal:  Am J Public Health       Date:  2010-02-18       Impact factor: 9.308

Review 2.  Air Pollution and Cardiovascular Disease: JACC State-of-the-Art Review.

Authors:  Sanjay Rajagopalan; Sadeer G Al-Kindi; Robert D Brook
Journal:  J Am Coll Cardiol       Date:  2018-10-23       Impact factor: 24.094

3.  Air Pollution and Mortality in the Medicare Population.

Authors:  Qian Di; Yan Wang; Antonella Zanobetti; Yun Wang; Petros Koutrakis; Christine Choirat; Francesca Dominici; Joel D Schwartz
Journal:  N Engl J Med       Date:  2017-06-29       Impact factor: 91.245

4.  Short-term effects of air pollution on heart rate variability in senior adults in Steubenville, Ohio.

Authors:  Heike Luttmann-Gibson; Helen H Suh; Brent A Coull; Douglas W Dockery; Stefanie E Sarnat; Joel Schwartz; Peter H Stone; Diane R Gold
Journal:  J Occup Environ Med       Date:  2006-08       Impact factor: 2.162

5.  Particulate air pollution as a risk factor for ST-segment depression in patients with coronary artery disease.

Authors:  Kai Jen Chuang; Brent A Coull; Antonella Zanobetti; Helen Suh; Joel Schwartz; Peter H Stone; Augusto Litonjua; Frank E Speizer; Diane R Gold
Journal:  Circulation       Date:  2008-09-08       Impact factor: 29.690

6.  Particulate air pollution and risk of ST-segment depression during repeated submaximal exercise tests among subjects with coronary heart disease: the Exposure and Risk Assessment for Fine and Ultrafine Particles in Ambient Air (ULTRA) study.

Authors:  Juha Pekkanen; Annette Peters; Gerard Hoek; Pekka Tiittanen; Bert Brunekreef; Jeroen de Hartog; Joachim Heinrich; Angela Ibald-Mulli; Wolfgang G Kreyling; Timo Lanki; Kirsi L Timonen; Esko Vanninen
Journal:  Circulation       Date:  2002-08-20       Impact factor: 29.690

7.  Long-Term Exposure to Particulate Air Pollution Is Associated With 30-Day Readmissions and Hospital Visits Among Patients With Heart Failure.

Authors:  Cavin K Ward-Caviness; Mahdieh Danesh Yazdi; Joshua Moyer; Anne M Weaver; Wayne E Cascio; Qian Di; Joel D Schwartz; David Diaz-Sanchez
Journal:  J Am Heart Assoc       Date:  2021-05-04       Impact factor: 5.501

Review 8.  Obesity and the cardiovascular health effects of fine particulate air pollution.

Authors:  Scott Weichenthal; Jane A Hoppin; Francois Reeves
Journal:  Obesity (Silver Spring)       Date:  2014-03-27       Impact factor: 5.002

Review 9.  A Systematic Review of the Short-Term Health Effects of Air Pollution in Persons Living with Coronary Heart Disease.

Authors:  Darren E R Warburton; Shannon S D Bredin; Erin M Shellington; Christie Cole; Amanda de Faye; Jennifer Harris; David D Kim; Alan Abelsohn
Journal:  J Clin Med       Date:  2019-02-24       Impact factor: 4.241

10.  Cardiopulmonary Effects of Fine Particulate Matter Exposure among Older Adults, during Wildfire and Non-Wildfire Periods, in the United States 2008-2010.

Authors:  Stephanie DeFlorio-Barker; James Crooks; Jeanette Reyes; Ana G Rappold
Journal:  Environ Health Perspect       Date:  2019-03       Impact factor: 9.031

View more
  1 in total

Review 1.  Recent Insights into Particulate Matter (PM2.5)-Mediated Toxicity in Humans: An Overview.

Authors:  Prakash Thangavel; Duckshin Park; Young-Chul Lee
Journal:  Int J Environ Res Public Health       Date:  2022-06-19       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.